Published in Pharma Investments, Ventures and Law Weekly, May 16th, 2004
These options were granted with the approval of the compensation committee of the board of directors and are in addition to 300,000 options granted Minogue under Abiomed's established employee stock option plan.
Terms of the inducement grant options are: exercise price equal to the fair market value on the grant date (April 5, 2004); 10-year duration; and vesting at the rate of 25% per year for the first 4 years of service with the company.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly